Summary
Eli Lilly and Company (LLY) filed an 8-K on July 24, 2013, reporting its second quarter and year-to-date financial results for the period ended June 30, 2013. The filing primarily announces the release of its earnings press release and related financial statements, which were issued on the same date. Investors should note that the company utilizes non-GAAP financial measures, such as non-GAAP net income and earnings per share, to provide additional insights into its ongoing operations and to facilitate period-over-period comparisons. These non-GAAP measures exclude items that are typically volatile and difficult to predict, aiming to present a clearer view of operational trends. Management uses these measures internally for performance evaluation and resource allocation. The accompanying press release, attached as Exhibit 99 to this 8-K, provides detailed financial performance for the second quarter and the first six months of 2013. While the 8-K itself is a notification of the earnings release, the furnished press release contains the substantive financial information and any forward-looking guidance. Investors are advised to review these non-GAAP measures alongside GAAP figures, as they are intended as a supplement, not a replacement, for traditional financial reporting.
Key Highlights
- 1Eli Lilly announced its second quarter and six-month financial results for the period ending June 30, 2013.
- 2The company issued a press release on July 24, 2013, detailing these financial results.
- 3A teleconference for analysts and media was held on July 24, 2013, to discuss the quarterly results.
- 4Lilly utilizes non-GAAP financial measures (e.g., non-GAAP net income, EPS) in its reporting.
- 5Non-GAAP measures are used to provide insights into ongoing operations and facilitate comparisons by excluding volatile items.
- 6Management uses non-GAAP measures internally for performance evaluation and resource allocation.
- 7The press release and related financial statements are furnished as Exhibit 99 to the 8-K filing.